Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 5Lung Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 2Hematologic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Liver Diseases 1HER2+ Metastatic Breast Cancer (MBC) 1Fibrosis 1Diabetes Mellitus 1Colorectal Cancer Screening 1Colonic Neoplasms 1Cardiovascular Diseases 1Cancer Screening 1

Interventions

Bevacizumab 69atezolizumab 54lenvatinib 42durvalumab 42Nivolumab 38pembrolizumab 35tremelimumab 28Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 17Ipilimumab 15Sorafenib 14regorafenib 13cabozantinib 13Radiosurgery 13Radiotherapy 12apatinib 11Blood Specimen Collection 11Immunoglobulin G 10camrelizumab 9Immune Checkpoint Inhibitors 9Disulfides 9X-Rays 8Cyclophosphamide 8donafenib 7Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Patient Navigation × 1 year × Clear all
NCT07568457 2026-05-05

Social Determinants of Health HCC Trial

University of Southern California

Phase NA Not yet recruiting
75 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

University of Texas Southwestern Medical Center

Phase NA Completed
1,800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡